Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research
The EC is responsible for the overall management, oversight and reporting of the trial.
|Robert Califf||US||Cardiologist (Chair)|
|Rury Holman||UK||Endocrinologist (Co-Chair)|
The DMC ensure the safety of the trial participants by undertaking regular independent evaluation of trial safety data.
|Antonio Gotto||US||Cardiologist (Chair)|
The Steering Committee is comprised of lead investigators from participating countries and includes experts in cardiology and diabetes. The main roles of the steering committee are to review and approve the study design, all protocol amendments, substudies, and study progress and to transmit critical information to individual investigators.